
Explore how OCD and schizophrenia overlap, complicating diagnosis and care, and learn spectrum-based strategies and treatment pitfalls for managing schizo-obsessive symptoms.
Data published in The New England Journal of Medicine shows promise for a novel schizophrenia treatment.
Stephen Brannan, MD, Chief Medical Officer of Karuna Therapeutics, talks more on the phase II clinical data for KarXT, published in the
To read more, see
Dr Brannan is chief medical officer at Karuna Therapeutics and a neuroscience drug development expert.


